A remarkable finding of the present study is the significant low expression levels of both necroptosis markers (MLKL and RIPK3) and autophagy-related protein (Beclin-1) in ITP patients who respond to corticosteroid therapy than that in non-responder ITP patients. This evidence concerns the gene MLKL and autoimmune thrombocytopenic purpura.